BioPorto AS (BIOPOR):企業の財務・戦略的SWOT分析

◆英語タイトル:BioPorto AS (BIOPOR) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME3918793FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

BioPorto AS (BIOPOR) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

BioPorto AS (BioPorto) is an in-vitro diagnostics company which offers a wide range of specialized monoclonal antibodies, antibody-based diagnostic assays, and biomarkers for the identification and management of seriously ill patients. It employs these monoclonal antibodies in its own biomarker programs. The company’s comprehensive antibodies’ portfolio serves the R&D requirements of diagnostic and pharmaceutical companies. BioPorto evaluates its biomarker candidates derived from its antibody portfolio for early detection of acute kidney injury, and mannan-binding lectin (MBL) for immune response, and also investigates potential candidates in antibiotics, and immune defense. The company distributes its products worldwide through its own sales team, distributors, and through partnership with original equipment manufacturers (OEMs). It has subsidiaries in Denmark, and the US. BioPorto is headquartered in Copenhagen, Denmark.

BioPorto AS Key Recent Developments

Nov 18,2020: BioPorto announces Q3 2020 report
Aug 19,2020: BioPorto announces q2 2020 report
May 07,2020: BioPorto announces Q1 2020 report
Apr 01,2020: BioPorto and SDU in collaboration to fast track development of test to detect COVID-19 in less than 10 minutes
Mar 11,2020: BioPorto announces the 2019 Annual Report

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
BioPorto AS – Key Facts
BioPorto AS – Key Employees
BioPorto AS – Key Employee Biographies
BioPorto AS – Major Products and Services
BioPorto AS – History
BioPorto AS – Company Statement
BioPorto AS – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
BioPorto AS – Business Description
Product Category: Antibodies
Overview
Performance
Key Stats
Product Category: ELISA Kits
Overview
Product Category: ELISA MBL Kits
Performance
Product Category: NGAL Revenue
Overview
Performance
Product Category: Other Products and Licenses
Performance
Product Category: Royalty
Performance
Geographical Segment: Asia
Performance
Geographical Segment: Europe
Performance
Geographical Segment: North America
Performance
Geographical Segment: Other Countries
Performance
Geographical Segment: Rest of Europe
Performance
R&D Overview
BioPorto AS – Corporate Strategy
BioPorto AS – SWOT Analysis
SWOT Analysis – Overview
BioPorto AS – Strengths
BioPorto AS – Weaknesses
BioPorto AS – Opportunities
BioPorto AS – Threats
BioPorto AS – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
BioPorto AS, Medical Equipment, Deals By Year, 2014 to YTD 2020
BioPorto AS, Medical Equipment, Deals By Type, 2014 to YTD 2020
BioPorto AS, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 18, 2020: BioPorto announces Q3 2020 report
Aug 19, 2020: BioPorto announces q2 2020 report
May 07, 2020: BioPorto announces Q1 2020 report
Apr 01, 2020: BioPorto and SDU in collaboration to fast track development of test to detect COVID-19 in less than 10 minutes
Mar 11, 2020: BioPorto announces the 2019 Annual Report
Feb 26, 2020: BioPorto announces preliminary financial result for 2019, guidance for 2020 and postpones publication of audited annual report for 2019 to March 11, 2020
Aug 15, 2019: BioPorto announces Q2 2019 report
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
BioPorto AS, Key Facts
BioPorto AS, Key Employees
BioPorto AS, Key Employee Biographies
BioPorto AS, Major Products and Services
BioPorto AS, History
BioPorto AS, Subsidiaries
BioPorto AS, Key Competitors
BioPorto AS, Ratios based on current share price
BioPorto AS, Annual Ratios
BioPorto AS, Annual Ratios (Cont...1)
BioPorto AS, Interim Ratios
BioPorto AS, Medical Equipment, Deals By Year, 2014 to YTD 2020
BioPorto AS, Medical Equipment, Deals By Type, 2014 to YTD 2020
BioPorto AS, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[BioPorto AS (BIOPOR):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sterling Holiday Resorts (India) Limited:企業の戦略・SWOT・財務情報
    Sterling Holiday Resorts (India) Limited - Strategy, SWOT and Corporate Finance Report Summary Sterling Holiday Resorts (India) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • AbbVie Inc (ABBV):医療機器:M&Aディール及び事業提携情報
    Summary AbbVie Inc (AbbVie) is a research-based biopharmaceutical company that develops, manufactures and commercializes advanced therapies for treating complex and serious diseases. It provides pharmaceutical drugs to treat conditions in rheumatology, gastroenterology, dermatology, oncology, virolo …
  • C.H. Bailey PLC:企業の戦略・SWOT・財務情報
    C.H. Bailey PLC - Strategy, SWOT and Corporate Finance Report Summary C.H. Bailey PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Dairyland Power Cooperative:企業の戦略的SWOT分析
    Dairyland Power Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Bashneft (BANE):石油・ガス:M&Aディール及び事業提携情報
    Summary Bashneft is a vertically integrated oil and gas company. It operates in the oil and gas production, refining, petrochemical production, marketing and distribution of oil and petroleum products. It sales crude oil, petroleum products and petrochemical products to the domestic market. The comp …
  • Healthcare Locums Ltd:企業の戦略的SWOT分析
    Healthcare Locums Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Stemline Therapeutics Inc (STML):企業の財務・戦略的SWOT分析
    Summary Stemline Therapeutics Inc (Stemline) is a clinical stage biopharmaceutical company that develops therapeutics to treat cancer stem cells and tumor bulk. The company has developed discovery platform StemScreen to identify novel compounds that target and kill cancer stem cells. Its products pi …
  • S&T Dynamics Co., Ltd.:企業の戦略・SWOT・財務情報
    S&T Dynamics Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary S&T Dynamics Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Websol Energy System Ltd (WEBELSOLAR):企業の財務・戦略的SWOT分析
    Summary Websol Energy System Ltd (Websol) is an alternate energy company that offers manufacturing of photovoltaic crystalline solar cells and the related modules. The company offers products such as pv solar cell and pv solar module. Its pv solar cell includes multi crystalline 4bb pv solar cell, m …
  • Ecobee Inc:電力:M&Aディール及び事業提携情報
    Summary Ecobee Inc (Ecobee) is a thermostat device provider. The company offers ecobee swith plus, ecobee four, ecobee four smarter bundle, ecobee three lite, ecobee three lite smarter bundle, refurbished ecobee three, EMS Si and room sensors. Its products are controlled through voice control and mo …
  • BioMarin Pharmaceutical Inc (BMRN):医療機器:M&Aディール及び事業提携情報
    Summary BioMarin Pharmaceutical Inc (BioMarin) is a biopharmaceutical company which develops and commercializes innovative pharmaceuticals for treatment of serious diseases and medical conditions, such as Kyndrisa (drisapersen), Duchenne muscular dystrophy (DMD), phenylketonuria (PKU), achondroplasi …
  • Sammons Enterprises Inc:企業の戦略・SWOT・財務情報
    Sammons Enterprises Inc - Strategy, SWOT and Corporate Finance Report Summary Sammons Enterprises Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Saras S.p.A. (SRS):電力:M&Aディール及び事業提携情報
    Summary Saras S.p.A. (Saras) is crude oil refiner and operates refining, marketing, power generation and wind power businesses. The company’s major refinery is Sarroch refinery, on the Southwestern coast of Sardinia. Saras is also active in the production and sale of electricity, and offers industri …
  • Otto Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Otto Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Otto Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the ope …
  • Siemens Heat Transfer Technology BV:企業の戦略的SWOT分析
    Siemens Heat Transfer Technology BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Gedeon Richter Plc:企業の戦略・SWOT・財務分析
    Gedeon Richter Plc - Strategy, SWOT and Corporate Finance Report Summary Gedeon Richter Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Commonwealth Scientific and Industrial Research Organisation:製薬・医療:M&Aディール及び事業提携情報
    Summary Commonwealth Scientific and Industrial Research Organisation (CSIRO) is a national science agency that conducts research in climate adaptation, bio-security, renewable and energy, farming and food production, and information technology, and mining and manufacturing services, and others. The …
  • AutoCanada Inc.:企業のM&A・事業提携・投資動向
    AutoCanada Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's AutoCanada Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Sanshin Electronics Co., Ltd.:企業の戦略・SWOT・財務分析
    Sanshin Electronics Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sanshin Electronics Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Edion Corporation (2730):企業の財務・戦略的SWOT分析
    Edion Corporation (2730) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆